These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 25746966

  • 1. Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults.
    Fingleton J, Travers J, Williams M, Charles T, Bowles D, Strik R, Shirtcliffe P, Weatherall M, Beasley R, New Zealand Respiratory Health Survey Study Group.
    J Allergy Clin Immunol; 2015 Sep; 136(3):601-9. PubMed ID: 25746966
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
    Barnes PJ.
    J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
    [Abstract] [Full Text] [Related]

  • 3. The Asthma-COPD Overlap Syndrome.
    Postma DS, Rabe KF.
    N Engl J Med; 2015 Sep 24; 373(13):1241-9. PubMed ID: 26398072
    [Abstract] [Full Text] [Related]

  • 4. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome.
    Lim HS, Choi SM, Lee J, Park YS, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Lee CH.
    Ann Allergy Asthma Immunol; 2014 Dec 24; 113(6):652-7. PubMed ID: 25280465
    [Abstract] [Full Text] [Related]

  • 5. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep 24; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 6. Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?
    Reddel HK.
    J Allergy Clin Immunol; 2015 Sep 24; 136(3):546-52. PubMed ID: 26343938
    [Abstract] [Full Text] [Related]

  • 7. Phenotypes of symptomatic airways disease in China and New Zealand.
    Fingleton J, Huang K, Weatherall M, Guo Y, Ivanov S, Bruijnzeel P, Zhang H, Wang W, Beasley R, Wang C, NZ–China Study Group.
    Eur Respir J; 2017 Dec 24; 50(6):. PubMed ID: 29217598
    [Abstract] [Full Text] [Related]

  • 8. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC, Hurst MM.
    Pharmacol Ther; 2011 May 24; 130(2):114-43. PubMed ID: 21276815
    [Abstract] [Full Text] [Related]

  • 9. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.
    Pulm Pharmacol Ther; 2014 Feb 24; 27(1):52-6. PubMed ID: 23583566
    [Abstract] [Full Text] [Related]

  • 10. Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions.
    Wurst KE, St Laurent S, Hinds D, Davis KJ.
    COPD; 2017 Apr 24; 14(2):200-209. PubMed ID: 28103123
    [Abstract] [Full Text] [Related]

  • 11. Muscarinic Receptor Antagonists.
    Matera MG, Cazzola M.
    Handb Exp Pharmacol; 2017 Apr 24; 237():41-62. PubMed ID: 27787709
    [Abstract] [Full Text] [Related]

  • 12. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M, Novelli F, Vagaggini B, Braido F, Papi A, Sanduzzi A, Santus P, Scichilone N, Paggiaro P.
    Pulm Pharmacol Ther; 2015 Feb 24; 30():44-50. PubMed ID: 25445928
    [Abstract] [Full Text] [Related]

  • 13. What pulmonologists think about the asthma-COPD overlap syndrome.
    Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.
    Int J Chron Obstruct Pulmon Dis; 2015 Feb 24; 10():1321-30. PubMed ID: 26270415
    [Abstract] [Full Text] [Related]

  • 14. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease.
    Gordon J, Panos RJ.
    Expert Opin Drug Metab Toxicol; 2010 Mar 24; 6(3):381-92. PubMed ID: 20163324
    [Abstract] [Full Text] [Related]

  • 15. Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD.
    Kempsford R, Norris V, Siederer S.
    Pulm Pharmacol Ther; 2013 Apr 24; 26(2):256-64. PubMed ID: 23232038
    [Abstract] [Full Text] [Related]

  • 16. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO, Hawkins C, Barbandi F.
    J Am Board Fam Med; 2013 Apr 24; 26(4):470-7. PubMed ID: 23833163
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Challenges in the management of asthma associated with smoking-induced airway diseases.
    Thomson NC.
    Expert Opin Pharmacother; 2018 Oct 24; 19(14):1565-1579. PubMed ID: 30196731
    [Abstract] [Full Text] [Related]

  • 19. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
    Patel M, Thomson NC.
    Expert Opin Pharmacother; 2011 May 24; 12(7):1133-41. PubMed ID: 21453221
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R, SMART Study Group.
    Lancet Respir Med; 2013 Mar 24; 1(1):32-42. PubMed ID: 24321802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.